Recently, programmed death-ligand 1 (PD-L1) is found to be involved in the regulation of PI3K/AKT pathway, the multifaceted functions of PD-L1 beyond its well-known role in immune suppression of T cells, such as promoting EMT and sustaining cancer stemness [13]. This evidence concerns the gene AKT1 and cancer.